Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non–ST-segment elevation acute myocardial infarction-Reference-Cited by-同舟云学术

Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non–ST-segment elevation acute myocardial infarction

Published:2001-12 Issue:11 Volume:88 Page:1230-1234
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Berkowitz Scott D,Stinnett Sandra,Cohen Marc,Fromell Gregg J,Bigonzi Frederique

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia;Gurfinkel;J Am Coll Cardiol,1995

2. Low-molecular-weight heparin during instability in coronary artery disease;Lancet,1996

3. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease (FRIC) study;Klein;Circulation,1997

4. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group;Cohen;N Engl J Med,1997

5. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction;Eur Heart J,1999

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of Stanch Belt Plus in Postoperative Management after Endovascular Neurosurgery;Journal of Neuroendovascular Therapy;2023

2. Case-control study of postprocedural arterial puncture site hemorrhage after neuroendovascular treatment;NAGOYA J MED SCI;2021

3. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients;Cochrane Database of Systematic Reviews;2017-04-21

4. Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial;American Heart Journal;2014-07

5. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation;The Journal of Heart and Lung Transplantation;2014-01